Oculis (OCSAW) Competitors $10.94 -0.06 (-0.54%) As of 02:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends OCSAW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Oculis stock or one of its competitors? The main competitors of Oculis include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Oculis vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Oculis (NASDAQ:OCSAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Which has stronger earnings and valuation, OCSAW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOculisN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is OCSAW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets OculisN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community favor OCSAW or ATNFW? Oculis and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOculisN/AN/A180 Life SciencesN/AN/A Does the media refer more to OCSAW or ATNFW? In the previous week, Oculis' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Oculis Neutral 180 Life Sciences Neutral SummaryOculis and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks. Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCSAW vs. The Competition Export to ExcelMetricOculisBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$174.27M$5.44B$9.21BDividend YieldN/A3.64%5.36%3.97%P/E RatioN/A127.5888.7617.50Price / SalesN/A18,647.151,257.1780.08Price / CashN/A13.0144.6537.70Price / BookN/A9.135.034.72Net IncomeN/A-$20.89M$117.98M$224.54M7 Day Performance3.26%3.66%3.02%1.74%1 Month Performance106.43%4.51%4.32%4.42%1 Year Performance851.39%122.41%26.94%22.00% Oculis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCSAWOculisN/A$10.94-0.5%N/A+856.5%$0.00N/A0.0032ATNFW180 Life SciencesN/A$0.01+3.0%N/A+81.0%$0.00N/A0.007Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.02-13.4%N/AN/A$0.00$502,409.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+19.5%N/A+42.8%$0.00N/A0.0080Gap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01+14.7%N/A-71.9%$0.00N/A0.0059BCTXWBriaCell TherapeuticsN/A$0.18+11.6%N/A-93.1%$0.00N/A0.008CDIOWCardio DiagnosticsN/A$0.06-19.0%N/A-50.4%$0.00$35,688.000.007Positive NewsGap DownCTCXWCarmellN/A$0.05+22.9%N/A-82.0%$0.00$32,839.000.0014Positive NewsGap UpCELUWCelularityN/A$0.03-1.8%N/A+39.3%$0.00$48.20M0.00220CEROWCERo TherapeuticsN/A$0.02-7.6%N/AN/A$0.00N/A0.008Gap Down Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OCSAW) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCSAW Stock Alerts